Critical role for CXC chemokine ligand 16 (SR-PSOX) in Th1 response mediated by NKT cells

Journal of Immunology

Volumn 179, Issue 12, 2007, Pages 8172-8179

  Shimaoka, Takeshi ^a,b   Seino, Ken Ichiro ^c,d   Kume, Noriaki ^a   Minami, Manabu ^a   Nishime, Chiyoko ^e   Suematsu, Makoto ^e   Kita, Toru ^a   Taniguchi, Masaru ^c   Matsushima, Kouji ^b   Yonehara, Shin ^a  

^a KYOTO UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c RIKEN Center for Integrative Medical Sciences   (Japan)

^d ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e KEIO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA GALACTOSYLCERAMIDE; CXCL16 CHEMOKINE; GAMMA INTERFERON; INTERLEUKIN 4; SCAVENGER RECEPTOR; ALPHA-GALACTOSYLCERAMIDE; CXCL16 PROTEIN, MOUSE; GALACTOSYLCERAMIDE; GRANULOCYTE CHEMOTACTIC PROTEIN 2; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL CULTURE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; IMMUNE RESPONSE; IMMUNOREACTIVITY; IN VIVO STUDY; LIVER CELL; MOUSE; MUTANT; NATURAL KILLER T CELL; NONHUMAN; PRIORITY JOURNAL; PROPIONIBACTERIUM ACNES; TH1 CELL; ANIMAL; BACTERIAL INFECTION; GENETICS; IMMUNOLOGY; LIVER; METABOLISM; MOUSE MUTANT; NATURAL KILLER CELL; PHYSIOLOGY;

ANIMALS; CHEMOKINE CXCL6; GALACTOSYLCERAMIDES; GRAM-POSITIVE BACTERIAL INFECTIONS; INTERFERON TYPE II; KILLER CELLS, NATURAL; LIVER; MICE; MICE, KNOCKOUT; PROPIONIBACTERIUM ACNES; TH1 CELLS;

EID: 40049104573     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.179.12.8172     Document Type: Article

References (34)

1. Seino, K., and M. Taniguchi. 2004. Functional roles of NKT cell in the immune system. Front Biosci. 9: 2577-2587.
2. Kronenberg, M. 2005. Toward an understanding of NKT cell biology: progress and paradoxes. Annu. Rev. Immunol. 23: 877-900.
3. Van Kaer, L. 2005. α-Galactosylceramide therapy for autoimmune diseases: prospects and obstacles. Nat. Rev. Immunol. 5: 31-42.
4. Kronenberg, M., and L. Gapin. 2002. The unconventional lifestyle of NKT cells. Nat. Rev. Immunol. 2: 557-568.
5. Hayakawa, Y., K. Takeda, H. Yagita, M. J. Smyth, L. Van Kaer, K. Okumura, and I. Saiki. 2002. IFN-γ-mediated inhibition of tumor angiogenesis by natural killer T-cell ligand, α-galactosylceramide. Blood 100: 1728-1733.
6. Seino, K., S. Fujii, M. Harada, S. Motohashi, T. Nakayama, T. Fujisawa, and M. Taniguchi. 2005. Vα14 NKT cell-mediated anti-tumor responses and their clinical application. Springer Semin. Immunopathol. 27: 65-74.
7. Sharif, S., G. A. Arreaza, P. Zucker, Q. S. Mi, J. Sondhi, O. V. Naidenko, M. Kronenberg, Y. Koezuka, T. L. Delovitch, J. M. Gombert, et al. 2001. Activation of natural killer T cells by α-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes. Nat. Med. 7: 1057-1062.
8. Hong, S., M. T. Wilson, I. Serizawa, L. Wu, N. Singh, O. V. Naidenko, T. Miura, T. Haba, D. C. Scherer, J. Wei, M. Kronenberg, Y. Koezuka, and L. Van Kaer. 2001. The natural killer T-cell ligand α-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice. Nat. Med. 7: 1052-1056.
9. -(NKT) thymocytes prevent insulin-dependent diabetes mellitus in nonobese diabetic (NOD)/Lt mice by the influence of interleukin (IL)-4 and/or IL-10. J. Exp. Med. 187: 1047-1056.
10. Miyamoto, K., S. Miyake, and T. Yamamura. 2001. A synthetic glycolipid prevents autoimmune encephalomyelitis by inducing TH2 bias of natural killer T cells. Nature 413: 531-534.
11. Hayakawa, Y., K. Takeda, H. Yagita, L. Van Kaer, I. Saiki, and K. Okumura. 2001. Differential regulation of Th1 and Th2 functions of NKT cells by CD28 and CD40 costimulatory pathways. J. Immunol. 166: 6012-6018.
12. Matsumoto, G., E. Kubota, Y. Omi, U. Lee, and J. M. Penninger. 2004. Essential role of LFA-1 in activating Th2-like responses by α- galactosylceramide-activated NKT cells. J. Immunol. 173: 4976-4984.
13. Moser, B., and P. Loetscher. 2001. Lymphocyte traffic control by chemokines. Nat Immunol. 2: 123-128.
14. Cyster, J. G. 2005. Chemokines, sphingosine-1-phosphate, and cell migration in secondary lymphoid organs. Annu. Rev. Immunol. 23: 127-159.
15. Matloubian, M., A. David, S. Engel, J. E. Ryan, and J. G. Cyster. 2000. A transmembrane CXC chemokine is a ligand for HIV-coreceptor Bonzo. Nat. Immunol. 1: 298-304.
16. Wilbanks, A., S. C. Zondlo, K. Murphy, S. Mak, D. Soler, P. Langdon, D. P. Andrew, L. Wu, and M. Briskin. 2001. Expression cloning of the STRL33/ BONZO/TYMSTRligand reveals elements of CC, CXC, and CX3C chemokines. J. Immunol. 166: 5145-5154.
17. Shimaoka, T., N. Kume, M. Minami, K. Hayashida, H. Kataoka, T. Kita, and S. Yonehara. 2000. Molecular cloning of a novel scavenger receptor for oxidized low density lipoprotein, SR-PSOX, on macrophages. J. Biol. Chem. 275: 40663-40666.
18. Shimaoka, T., T. Nakayama, N. Kume, S. Takahashi, J. Yamaguchi, M. Minami, K. Hayashida, T. Kita, J. Ohsumi, O. Yoshie, and S. Yonehara. 2003. Cutting edge: SR-PSOX/CXC chemokine ligand 16 mediates bacterial phagocytosis by APCs through its chemokine domain. J. Immunol. 171: 1647-1651.
19. + T cells. J. Leukocyte Biol. 77: 777-786.
20. Kim, C. H., E. J. Kunkel, J. Boisvert, B. Johnston, J. J. Campbell, M. C. Genovese, H. B. Greenberg, and E. C. Butcher. 2001. Bonzo/CXCR6 expression defines type 1-polarized T-cell subsets with extralymphoid tissue homing potential. J. Clin. Invest. 107: 595-601.
21. Fukumoto, N., T. Shimaoka, H. Fujimura, S. Sakoda, M. Tanaka, T. Kita, and S. Yonehara. 2004. Critical roles of CXC chemokine ligand 16/scavenger receptor that binds phosphatidylserine and oxidized lipoprotein in the pathogenesis of both acute and adoptive transfer experimental autoimmune encephalomyelitis. J. Immunol. 173: 1620-1627.
22. + lymphocytes to inflamed liver. J. Immunol. 174: 277-283.
23. + NKT cells patrolling liver sinusoids. PLoS Biol. 3: e113.
24. Jiang, X., T. Shimaoka, S. Kojo, M. Harada, H. Watarai, H. Wakao, N. Ohkohchi, S. Yonehara, M. Taniguchi, and K. Seino. 2005. Cutting edge: critical role of CXCL16/CXCR6 in NKT cell trafficking in allograft tolerance. J. Immunol. 175: 2051-2055.
25. Cui, J., T. Shin, T. Kawano, H. Sato, E. Kondo, I. Toura, Y. Kaneko, H. Koseki, M. Kanno, and M. Taniguchi. 1997. Requirement for Vα14 NKT cells in IL-12-mediated rejection of tumors. Science 278: 1623-1626.
26. Kawano, T., J. Cui, Y. Koezuka, I. Toura, Y. Kaneko, K. Motoki, H. Ueno, R. Nakagawa, H. Sato, E. Kondo, et al. 1997. CD1d-restricted and TCR-mediated activation of Vα14 NKT cells by glycosylceramides. Science 278: 1626-1629.
27. Shimaoka, T., T. Nakayama, N. Fukumoto, N. Kume, S. Takahashi, J. Yamaguchi, M. Minami, K. Hayashida, T. Kita, J. Ohsumi, et al. 2004. Cell surface-anchored SR-PSOX/CXC chemokine ligand 16 mediates firm adhesion of CXC chemokine receptor 6-expressing cells. J. Leukocyte Biol. 75: 267-274.
28. Goossens, P. L., H. Jouin, G. Marchal, and G. Milon. 1990. Isolation and flow cytometric analysis of the free lymphomyeloid cells present in murine liver. J. Immunol. Methods 132: 137-144.
29. Watanabe, H., K. Ohtsuka, M. Kimura, Y. Ikarashi, K. Ohmori, A. Kusumi, T. Ohteki, S. Seki, and T. Abo. 1992. Details of an isolation method for hepatic lymphocytes in mice. J. Immunol. Methods 146: 145-154.
30. Trobonjaca, Z., F. Leithauser, P. Moller, R. Schirmbeck, and J. Reimann. 2001. Activating immunity in the liver, I: liver dendritic cells (but not hepatocytes) are potent activators of IFN-γ release by liver NKT cells. J. Immunol. 167: 1413-1422.
31. Dong, H., N. Toyoda, H. Yoneyama, M. Kurachi, T. Kasahara, Y. Kobayashi, H. Inadera, S. Hashimoto, and K. Matsushima. 2002. Gene expression profile analysis of the mouse liver during bacteria-induced fulminant hepatitis by a cDNA microarray system. Biochem. Biophys. Res. Commun. 298: 675-686.
32. Okamura, H., K. Kawaguchi, K. Shoji, and Y. Kawade. 1982. High-level induction of γ interferon with various mitogens in mice pretreated with Propionibacterium acnes. Infect. Immun. 38: 440-443.
33. + T cells but induces type I T cells in the liver by induction of IL-12 and IL-18 production from Kupffer cells. J. Immunol. 159: 97-106.
34. Zhou, D., J. Mattner, C. Cantu III, N. Schrantz, N. Yin, Y. Gao, Y. Sagiv, K. Hudspeth, Y. P. Wu, T. Yamashita, et al. 2004. Lysosomal glycosphingolipid recognition by NKT cells. Science 306: 1786-1789.